Insider trade

Director sold ~$1.65M of COLL shares in the open market

Traded Nov 12, 2025 · Filed Nov 14, 2025

Why it stands out

A board member of Collegium Pharmaceutical sold $1.65M of Collegium Pharmaceutical shares. Nobody planned it ahead of time.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Director$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,645,536

Shares × reported transaction price

Timing vs results

6 days after results of Nov 6, 2025, 106 days before results of Feb 26, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+0.5%	+0.5%	+0.1%
30 days	+7.8%	+0.9%	+7.0%
90 days	+1.7%	+2.6%	−0.9%
180 days	−25.8%	+11.0%	−36.7%

Past results only. Not a forecast.

The price reported in column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $46.805 to $47.51, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

10mo ago

Derivative exercise or conversion — not an open-market buy.

Scheduled in advance10mo ago

Scheduled in advance10mo ago